pLKO.1 shJUND puro
(Plasmid
#58698)
-
PurposeLentiviral shRNA vector for knockdown of human JUND
-
Depositing Lab
-
Sequence Information
Full plasmid sequence is not available for this item.
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 58698 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepLKO.1
-
Backbone manufacturerWeinberg Lab (Addgene plasmid 8453)
- Total vector size (bp) 7032
-
Vector typeMammalian Expression, Lentiviral
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)Stbl3
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameshJUND
-
gRNA/shRNA sequenceccggGCGCCTGGAAGAGAAAGTGAActcgagTTCACTTTCTCTTCCAGGCGCttttt
-
SpeciesH. sapiens (human)
-
GenBank IDNM_005354
-
Entrez GeneJUND (a.k.a. AP-1)
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site AgeI (unknown if destroyed)
- 3′ cloning site EcoRI (unknown if destroyed)
- 5′ sequencing primer LKO.1 5' (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
This construct was obtained from the TRC (#TRCN0000014974) and potently knocks down junD expression after 3 x 500 microL infection in MCF10A cells.
The specificity of this construct has been confirmed by addback with mouse junD, which is resistant to this shRNA.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pLKO.1 shJUND puro was a gift from Kevin Janes (Addgene plasmid # 58698 ; http://n2t.net/addgene:58698 ; RRID:Addgene_58698) -
For your References section:
A time- and matrix-dependent TGFBR3-JUND-KRT5 regulatory circuit in single breast epithelial cells and basal-like premalignancies. Wang CC, Bajikar SS, Jamal L, Atkins KA, Janes KA. Nat Cell Biol. 2014 Apr;16(4):345-56. doi: 10.1038/ncb2930. Epub 2014 Mar 23. 10.1038/ncb2930 PubMed 24658685